Babylon Holdings Limited (BBLN), Palantir (PLTR) Outline New Health-Based Partnership

Babylon Holdings Limited (NYSE: BBLN) and Palantir Technologies Inc. (NYSE: PLTR), a leading builder of operating systems for the modern enterprise -- today outlined the substantial progress they have made in a new partnership designed to deliver a revolution in the use of data to improve clinical delivery and care for Babylon’s members in the US healthcare marketplace.

The partnership, which began earlier this year, has seen Babylon utilize Palantir’s Foundry platform to enable the acceleration in the delivery of its digital-first personalized care through the integration of its Health Graph, which represents a 360-degree view of its members’ health and wellbeing.

“In an industry that has been built around incomplete, siloed and unstructured data,” said Dr. Ali Parsa, CEO of Babylon, “our partnership with Palantir is enabling us to bring a more integrated and intelligent approach to better understand a person’s holistic health and predict their potential future development. This is central to the delivery of better patient outcomes and a better overall experience. We hope that through this rapid transition to using Foundry as a powerful foundation for managing data, we can build one of the most advanced healthcare data platforms in the world, which will ultimately enable us to improve clinical operations and drive the effective delivery of healthcare.”

In less than two months, the Palantir Foundry platform provided Babylon with a rapid development environment to integrate over 100 Babylon data sources, resulting in over 80 billion data points and enabling the organization to accelerate its AI-enhanced capabilities through real time consumption of its Health Graph.

“Babylon’s digital-first and security-focused approach to healthcare is one of the most innovative in the world,” said Shyam Sankar, Chief Operating Officer of Palantir Technologies. “Foundry is trusted by healthcare institutions around the world – public and private – to serve as the operating system for clinical research, vaccine management, pharmaceuticals, and more. We are proud to work with Babylon on their mission to broadly deliver high-quality, personalized healthcare.”

As the partnership evolves, Babylon will continue to leverage Foundry in its focus on expanding the capabilities of the Babylon Health Graph, with the mission to revolutionize the actionability of healthcare data spanning a multitude of health services, devices, and legacy records sources. The goal is to support Babylon’s consenting members with the insights with which to better understand their health and allow them to engage at every step of the healthcare continuum.

Steve Davis, Babylon’s Chief Technology Officer added, “We believe that our platform approach to powering our products and services, supported by world-class software such as Palantir Foundry, allows us to advance our responsible integration of data and enable the rapid development of our AI-enhanced capabilities to deliver something truly exceptional. The combination of our Health Graph with the Palantir Foundry platform will allow us to produce a more complete, 360-degree view of our members and further enhance the interactions members have with our clinical teams."

To date, the partnership has created over 10 workflows with well over 100 engineers and scientists across Babylon engaged in driving rapid development across its AI services landscape.

You May Also Be Interested In

• IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
• Unilever (UL) shares jump as sales growth accelerate in Q1
• Meta shares dip on softer Q2 revenue guidance, elevated AI spending plans